Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2015-07-30 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 30, 2015, reporting the issuance of a press release announcing financial results for the fiscal quarter ended June 30, 2015. The text explicitly states that the press release is furnished as an exhibit and that the information is not deemed "filed" for certain legal purposes. The document does not contain the actual financial results or detailed financial statements but rather announces the release of such information. The length of the document is 4016 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full financial data itself, nor is it a full earnings release or quarterly report.
2015-07-30 English
AMENDMENT NO. 2
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 2 to a Form S-1 Registration Statement filed with the SEC. It references the Securities Act of 1933 and discusses registration of securities, offering details, underwriting, and related information. The document is a regulatory filing related to securities registration and amendments to the registration statement, not a financial report, earnings release, or other report type. It is not a full report but an amendment to a registration statement, which fits the category of Capital/Financing Update (CAP) as it relates to securities offering and capital raising activities.
2015-07-29 English
NOTICE AND PROXY STATEMENT
Proxy Solicitation & Information Statement
2015-07-28 English
PRELIMINARY NOTICE AND PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PRELIMINARY NOTICE AND PROXY STATEMENT' and is identified as a Schedule 14A filing with the SEC. It includes detailed information about the upcoming 2015 Annual Meeting of Stockholders, including proposals to be voted on, board nominations, executive compensation advisory vote, auditor ratification, and an amendment to the certificate of incorporation. The document contains governance information, director biographies, compensation details, and voting instructions. It is clearly a proxy statement intended to solicit shareholder votes for the annual meeting. The presence of the term 'Proxy Statement' and the Schedule 14A form confirms this classification. Therefore, the document is a Proxy Solicitation & Information Statement.
2015-07-17 English
POST-EFFECTIVE AMENDMENT
Capital/Financing Update Classification · 95% confidence The document is titled 'Post-Effective Amendment No. 1 to Form S-1 Registration Statement' filed with the SEC. It references updating and supplementing information contained in the Form S-1 registration statement, including information from the company's annual report on Form 10-K for the fiscal year ended March 31, 2015. The document is a registration statement amendment related to securities offering, including details about shares and warrants offered, underwriting, and risk factors. This type of filing is a post-effective amendment to a registration statement under the Securities Act of 1933, which is a capital raising and financing document. It is not an earnings release, annual report, or other financial report but rather a capital/financing update related to securities registration and offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2015-07-09 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 29, 2015, by Oculus Innovative Sciences, Inc. The content focuses on the submission of matters to a vote of security holders at a special meeting, specifically regarding approval of a reverse stock split and related amendments. It includes detailed voting results and mentions the NASDAQ listing status. The document is not a full financial report but an announcement of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4177 characters, which is relatively short and consistent with a voting results announcement rather than a full report.
2015-07-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.